.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Johnson and Johnson
Boehringer Ingelheim
Daiichi Sankyo
Deloitte
Chubb
Chinese Patent Office
QuintilesIMS
Colorcon
Novartis

Generated: June 22, 2017

DrugPatentWatch Database Preview

Ciprofloxacin hydrochloride; fluocinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ciprofloxacin hydrochloride; fluocinolone acetonide and what is the scope of ciprofloxacin hydrochloride; fluocinolone acetonide freedom to operate?

Ciprofloxacin hydrochloride; fluocinolone acetonide
is the generic ingredient in one branded drug marketed by Laboratorios Salvat and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ciprofloxacin hydrochloride; fluocinolone acetonide has fourteen patent family members in thirteen countries.

There are thirty-one drug master file entries for ciprofloxacin hydrochloride; fluocinolone acetonide. One supplier is listed for this compound.

Summary for Generic Name: ciprofloxacin hydrochloride; fluocinolone acetonide

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list31
Suppliers / Packagers: see list1
Clinical Trials: see list2,555
Drug Prices:see low prices
DailyMed Link:ciprofloxacin hydrochloride; fluocinolone acetonide at DailyMed

Pharmacology for Ingredient: ciprofloxacin hydrochloride; fluocinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Laboratorios Salvat
OTOVEL
ciprofloxacin hydrochloride; fluocinolone acetonide
SOLUTION/DROPS;OTIC208251-001Apr 29, 2016RXYesYes8,932,610► SubscribeY ► Subscribe
Laboratorios Salvat
OTOVEL
ciprofloxacin hydrochloride; fluocinolone acetonide
SOLUTION/DROPS;OTIC208251-001Apr 29, 2016RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ciprofloxacin hydrochloride; fluocinolone acetonide

Country Document Number Estimated Expiration
Australia2011223095► Subscribe
Spain2391721► Subscribe
Mexico2012010009► Subscribe
Russian Federation2549465► Subscribe
Japan2013521245► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0012France► SubscribePRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
C/GB12/058United Kingdom► SubscribePRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Baxter
Cerilliant
Dow
Mallinckrodt
Julphar
Fish and Richardson
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot